Craft

Advanced
  • Home
  •  / Chondrial Therapeutics
Chondrial Therapeutics

Chondrial Therapeutics

Total Funding

$23.6 M

Chondrial Therapeutics Summary

Company Summary

Overview
Chondrial Therapeutics is engaged in discovering and developing orphan drugs for mitochondrial diseases. The Company is focused on the treatment of rare mitochondrial diseases.
Type
Private
Status
Active
Founded
2013
HQ
Bala Cynwyd, PA, US | view all locations
Website
http://chondrialtherapeutics.com
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Carole Ben-Maimon, MD, Chief Executive Officer

    • David Bettoun, Vice President of Pre-Clinical Development

      • John Berman, Vice President of Finance and Operation

        • Jennifer Johansson, Vice President of Regulatory Affairs and Counsel

          LocationsView all

          2 locations detected

          • Bala Cynwyd, PA HQ

            United States

            3 Bala Plaza East, Suite 300

          • Indianapolis, IN

            United States

            4500 E 75th St

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX